SCHEMBL3398756

SCHEMBL3398756

CCOC(=O)c1nc(I)c2snc(-c3ccc(F)cc3)c2c1O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.53
ALDH1A1 P00352 4/20 0.53
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
MAPT P10636 3/20 0.53
HPGD P15428 2/20 0.53
PKM P14618 1/20 0.53
MAPK1 P28482 1/20 0.53
NPSR1 Q6W5P4 1/20 0.53
TRPM8 Q7Z2W7 1/20 0.46
GABRA2 P47869 1/20 0.42
GABRB2 P47870 1/20 0.42
PTGS2 P35354 1/20 0.42
ALOX5 P09917 1/20 0.41
LMNA P02545 4/20 0.41
SMN1; SMN2 Q16637 1/20 0.38
GRM6 O15303 1/20 0.38
PRKCZ Q05513 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MAPK14 Q16539 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3398759 0.90 KDM4E (0.54) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL3403511 0.89 TARBP2 (0.46) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL3401368 0.88 KDM4E (0.52) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL3401461 0.87 ALDH1A1 (0.51) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL3407275 0.87 ALDH1A1 (0.51) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL3398719 0.84 KDM4E (0.47) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL3403517 0.83 KDM4E (0.47) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL3402968 0.79 NPC1 (0.54) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL3402159 0.79 TARBP2 (0.47) KDM4EALDH1A1NPC1RAB9AMAPT
SCHEMBL3401768 0.79 ALDH1A1 (0.49) KDM4EALDH1A1NPC1RAB9AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9387200-B2 Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity FIBROGEN, INC. (US) 2016-07-12 US disclosed
US-20150209336-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN, INC. 2015-07-30 US disclosed
US-8952160-B2 Isothiazole-pyridine derivatives as modulators of HIF (hypoxia inducible factor) activity FIBROGEN, INC. (US) 2015-02-10 US disclosed
EP-2252619-B1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN INC (US) 2013-10-09 EP disclosed
US-20100330199-A1 ISOTHIAZOLE-PYRIDINE DERIVATES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN, INC. 2010-12-30 US disclosed
EP-2252619-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY Fibrogen, Inc. (US) 2010-11-24 EP disclosed
WO-2009089547-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY FIBROGEN, INC. (US) 2009-07-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100330199-A1 ISOTHIAZOLE-PYRIDINE DERIVATES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY HIF1A, HIF1AN, EGLN3 KDM4E 1095/4885ALDH1A1 256/4885NPC1 3156/4885
US-20150209336-A1 ISOTHIAZOLE-PYRIDINE DERIVATIVES AS MODULATORS OF HIF (HYPOXIA INDUCIBLE FACTOR) ACTIVITY HIF1A, HIF1AN, EGLN3 KDM4E 961/4885ALDH1A1 284/4885NPC1 3160/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.